NetraMark Holdings Inc

NetraMark Holdings Inc., based in Toronto, ON, specializes in revolutionizing clinical trial development through innovative artificial intelligence solutions. Their flagship product, NetraAI, leverages advanced algorithms to uncover hidden patient correlations and enhance decision-making in clinical trials.

In addition to NetraAI, the company offers tools such as NetraPlacebo and NetraGPT, which provide insights into placebo responses and enhance patient profiling, respectively. Founded by Dr. Joseph Geraci, a specialist in quantum machine learning and medical science, NetraMark is dedicated to improving the efficiency and reliability of clinical trials through cutting-edge technology.

Generated from the website